Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report.

Saponara M, Indio V, Pizzi C, Serban ED, Urbini M, Astolfi A, Paolisso P, Suarez SM, Nannini M, Pacini D, Agostini V, Leone O, Ambrosini V, Tarantino G, Fanti S, Niro F, Buia F, Attinà D, Pantaleo MA.

World J Clin Cases. 2019 Oct 6;7(19):3018-3026. doi: 10.12998/wjcc.v7.i19.3018.

2.

Merkel cell carcinoma: a prompt diagnosis to increase survival.

Chessa MA, Malosso M, Pepe F, Patrizi A, Telo S, Ambrosini V, Fanti S, Magnano M, Baraldi C, Corti B, Filippi F, Vaccari S, Pileri A, Bardazzi F.

J Eur Acad Dermatol Venereol. 2019 Jul 16. doi: 10.1111/jdv.15805. [Epub ahead of print] No abstract available.

PMID:
31310359
3.

18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy.

Zanoni L, Varani S, Attard L, Morigi JJ, Vanino E, Ortalli M, Fonti C, Viale P, Re MC, Fanti S, Ambrosini V.

Ann Nucl Med. 2019 Sep;33(9):716-723. doi: 10.1007/s12149-019-01381-6. Epub 2019 Jun 28.

PMID:
31254270
4.

Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis.

Ricci C, Ingaldi C, Alberici L, Brighi N, Santini D, Mosconi C, Ambrosini V, Campana D, Minni F, Casadei R.

Endocrine. 2019 Jun 21. doi: 10.1007/s12020-019-01984-z. [Epub ahead of print]

PMID:
31227991
5.

Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience.

Pagano N, Ricci C, Brighi N, Ingaldi C, Pugliese F, Santini D, Campana D, Mosconi C, Ambrosini V, Casadei R.

Endocrine. 2019 Jul;65(1):207-212. doi: 10.1007/s12020-019-01907-y. Epub 2019 Mar 27.

PMID:
30919286
6.

68Ga-DOTANOC and 18F-DOPA PET/CT: a site-specific approach to the imaging of parangliomas of the head and neck  and of the abdomen.

Calabrò D, Allegri V, Fanti S, Ambrosini V.

Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1393. doi: 10.1007/s00259-019-04299-3. Epub 2019 Mar 14. No abstract available.

PMID:
30874857
7.

A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience.

Ricci C, Campana D, Casadei C, Ingaldi C, Ambrosini V, Pagano N, Santini D, Mosconi C, Brighi N, Alberici L, Minni F, Casadei R.

Endocrine. 2019 Jun;64(3):702-707. doi: 10.1007/s12020-019-01870-8. Epub 2019 Feb 22.

PMID:
30796689
8.

68Ga-DOTANOC PET/CT Detects Multifocal Hepatocellular Carcinoma.

Tabacchi E, Campana D, Brighi N, Fanti S, Ambrosini V.

Clin Nucl Med. 2019 Mar;44(3):238-239. doi: 10.1097/RLU.0000000000002426.

PMID:
30672751
9.

18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature.

Saponara M, Ambrosini V, Nannini M, Gatto L, Astolfi A, Urbini M, Indio V, Fanti S, Pantaleo MA.

Ther Adv Med Oncol. 2018 Aug 30;10:1758835918793569. doi: 10.1177/1758835918793569. eCollection 2018.

10.

Nuclear Medicine Imaging of Prostate Cancer in the Elderly.

Castellucci P, Nanni C, Ambrosini V.

Semin Nucl Med. 2018 Nov;48(6):541-547. doi: 10.1053/j.semnuclmed.2018.07.004. Epub 2018 Aug 8. Review.

PMID:
30322480
11.

Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study.

Brighi N, Lamberti G, Maggio I, Manuzzi L, Ricci C, Casadei R, Santini D, Mosconi C, Lisotti A, Ambrosini V, Pantaleo MA, Campana D.

Dig Liver Dis. 2019 May;51(5):689-694. doi: 10.1016/j.dld.2018.09.013. Epub 2018 Sep 24.

PMID:
30314949
12.

Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanoma.

Comito F, Ambrosini V, Sperandi F, Melotti B, Ardizzoni A.

Anticancer Drugs. 2018 Nov;29(10):1026-1029. doi: 10.1097/CAD.0000000000000689.

PMID:
30095443
13.

High copper content in vineyard soils promotes modifications in photosynthetic parameters and morphological changes in the root system of 'Red Niagara' plantlets.

Ambrosini VG, Rosa DJ, Bastos de Melo GW, Zalamena J, Cella C, Simão DG, Souza da Silva L, Pessoa Dos Santos H, Toselli M, Tiecher TL, Brunetto G.

Plant Physiol Biochem. 2018 Jul;128:89-98. doi: 10.1016/j.plaphy.2018.05.011. Epub 2018 May 8.

PMID:
29772492
14.

The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?

Lamberti G, Brighi N, Maggio I, Manuzzi L, Peterle C, Ambrosini V, Ricci C, Casadei R, Campana D.

Int J Mol Sci. 2018 Mar 6;19(3). pii: E747. doi: 10.3390/ijms19030747. Review.

15.

Is radical surgery always curative in pancreatic neuroendocrine tumors? A cure model survival analysis.

Ricci C, Casadei R, Taffurelli G, Campana D, Ambrosini V, Pacilio CA, Santini D, Brighi N, Minni F.

Pancreatology. 2018 Apr;18(3):313-317. doi: 10.1016/j.pan.2018.02.008. Epub 2018 Feb 21.

PMID:
29487026
16.

Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis.

Ghedini P, Bossert I, Zanoni L, Ceci F, Graziani T, Castellucci P, Ambrosini V, Massari F, Nobili E, Melotti B, Musto A, Zoboli S, Antunovic L, Kirienko M, Chiti A, Mosconi C, Ardizzoni A, Golfieri R, Fanti S, Nanni C.

Eur J Nucl Med Mol Imaging. 2018 May;45(5):751-758. doi: 10.1007/s00259-017-3888-9. Epub 2017 Nov 30.

PMID:
29192364
17.

Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA.

Bozkurt MF, Virgolini I, Balogova S, Beheshti M, Rubello D, Decristoforo C, Ambrosini V, Kjaer A, Delgado-Bolton R, Kunikowska J, Oyen WJG, Chiti A, Giammarile F, Sundin A, Fanti S.

Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2150-2151. doi: 10.1007/s00259-017-3807-0. No abstract available.

PMID:
28856372
18.

Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies.

Bodei L, Ambrosini V, Herrmann K, Modlin I.

J Nucl Med. 2017 Nov;58(11):1718-1726. doi: 10.2967/jnumed.116.186361. Epub 2017 Aug 17. Review.

19.

Sporadic Small (≤20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis.

Ricci C, Casadei R, Taffurelli G, Pacilio CA, Campana D, Ambrosini V, Donatella S, Minni F.

Ann Surg Oncol. 2017 Sep;24(9):2603-2610. doi: 10.1245/s10434-017-5946-8. Epub 2017 Jul 5. Review.

PMID:
28681158
20.

Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA.

Bozkurt MF, Virgolini I, Balogova S, Beheshti M, Rubello D, Decristoforo C, Ambrosini V, Kjaer A, Delgado-Bolton R, Kunikowska J, Oyen WJG, Chiti A, Giammarile F, Sundin A, Fanti S.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1588-1601. doi: 10.1007/s00259-017-3728-y. Epub 2017 May 25. Erratum in: Eur J Nucl Med Mol Imaging. 2017 Aug 30;:.

PMID:
28547177
21.

Is surgery the best treatment for sporadic small (≤2 cm) non-functioning pancreatic neuroendocrine tumours? A single centre experience.

Ricci C, Taffurelli G, Campana D, Ambrosini V, Pacilio CA, Pagano N, Santini D, Brighi N, Minni F, Casadei R.

Pancreatology. 2017 May - Jun;17(3):471-477. doi: 10.1016/j.pan.2017.03.004. Epub 2017 Mar 15.

PMID:
28320587
22.

The Wandering Mesenteric Lymph Node: Delayed 68Ga-DOTANOC PET/CT Imaging to Overcome a Potential Pitfall.

Zanoni L, Zompatori M, Scalorbi F, Fanti S, Ambrosini V.

Clin Nucl Med. 2017 May;42(5):e253-e254. doi: 10.1097/RLU.0000000000001611.

PMID:
28263209
23.

Metachronous solitary metastasis to the thyroid gland from squamous cell carcinoma of the lung: a case report and literature review.

Gelsomino F, Lamberti G, Ambrosini V, Sperandi F, Agosti R, Morganti AG, Ardizzoni A.

Tumori. 2017 Nov 15;103(Suppl. 1):e12-e15. doi: 10.5301/tj.5000605. Review.

PMID:
28127743
24.

The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis.

Barrio M, Czernin J, Fanti S, Ambrosini V, Binse I, Du L, Eiber M, Herrmann K, Fendler WP.

J Nucl Med. 2017 May;58(5):756-761. doi: 10.2967/jnumed.116.185587. Epub 2017 Jan 12. Review.

25.

The combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment: The DERIST study.

Ambrosini V, Golino L, Niccoli G, Roberto M, Lisanti P, Ceravolo R, Bernardi G, Armigliato P, Gabrielli G, Chizzola G, De Paulis C, Crea F, Colombo A.

Cardiovasc Revasc Med. 2017 Apr - May;18(3):165-168. doi: 10.1016/j.carrev.2016.12.012. Epub 2016 Dec 21.

PMID:
28081977
26.

A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management.

Oberg K, Krenning E, Sundin A, Bodei L, Kidd M, Tesselaar M, Ambrosini V, Baum RP, Kulke M, Pavel M, Cwikla J, Drozdov I, Falconi M, Fazio N, Frilling A, Jensen R, Koopmans K, Korse T, Kwekkeboom D, Maecke H, Paganelli G, Salazar R, Severi S, Strosberg J, Prasad V, Scarpa A, Grossman A, Walenkamp A, Cives M, Virgolini I, Kjaer A, Modlin IM.

Endocr Connect. 2016 Sep;5(5):174-87. doi: 10.1530/EC-16-0043. Epub 2016 Aug 31.

27.

68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients.

Fendler WP, Barrio M, Spick C, Allen-Auerbach M, Ambrosini V, Benz M, Bluemel C, Grewal RK, Lapa C, Miederer M, Nicolas G, Schuster T, Czernin J, Herrmann K.

J Nucl Med. 2017 Feb;58(2):307-311. doi: 10.2967/jnumed.116.179192. Epub 2016 Aug 18.

28.

Pitfalls in Oncology: Osteoblastic Response Mimicking Bone Progression during Ceritinib Treatment in ALK-Rearranged NSCLC.

Gelsomino F, Ambrosini V, Melotti B, Sperandi F, Ardizzoni A.

J Thorac Oncol. 2016 Aug;11(8):e99-e101. doi: 10.1016/j.jtho.2016.04.002. Epub 2016 Apr 12. No abstract available.

29.

Large Porous Particles for Sustained Release of a Decoy Oligonucelotide and Poly(ethylenimine): Potential for Combined Therapy of Chronic Pseudomonas aeruginosa Lung Infections.

d'Angelo I, Perfetto B, Costabile G, Ambrosini V, Caputo P, Miro A, d'Emmanuele di Villa Bianca R, Sorrentino R, Donnarumma G, Quaglia F, Ungaro F.

Biomacromolecules. 2016 May 9;17(5):1561-71. doi: 10.1021/acs.biomac.5b01646. Epub 2016 Apr 1.

PMID:
27002689
30.

Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours.

Ricci C, Casadei R, Taffurelli G, Campana D, Ambrosini V, Pagano N, Santini D, De Giorgio R, Ingaldi C, Tomassetti P, Zani E, Minni F.

Pancreatology. 2016 May-Jun;16(3):403-10. doi: 10.1016/j.pan.2016.02.002. Epub 2016 Feb 16.

PMID:
26924664
31.

Effect of arbuscular mycorrhizal fungi on young vines in copper-contaminated soil.

Ambrosini VG, Voges JG, Canton L, Couto Rda R, Ferreira PA, Comin JJ, de Melo GW, Brunetto G, Soares CR.

Braz J Microbiol. 2015 Oct-Dec;46(4):1045-52. doi: 10.1590/S1517-838246420140622.

32.

Characterization of pectinase activity for enology from yeasts occurring in Argentine Bonarda grape.

Merín MG, Martín MC, Rantsiou K, Cocolin L, de Ambrosini VI.

Braz J Microbiol. 2015 Jul 1;46(3):815-23. doi: 10.1590/S1517-838246320140160. eCollection 2015 Jul-Sep.

33.

Prognostic Value of 68Ga-DOTANOC PET/CT SUVmax in Patients with Neuroendocrine Tumors of the Pancreas.

Ambrosini V, Campana D, Polverari G, Peterle C, Diodato S, Ricci C, Allegri V, Casadei R, Tomassetti P, Fanti S.

J Nucl Med. 2015 Dec;56(12):1843-8. doi: 10.2967/jnumed.115.162719. Epub 2015 Sep 24.

34.

Reduction of copper phytotoxicity by liming: A study of the root anatomy of young vines (Vitis labrusca L.).

Ambrosini VG, Rosa DJ, Corredor Prado JP, Borghezan M, Bastos de Melo GW, Fonsêca de Sousa Soares CR, Comin JJ, Simão DG, Brunetto G.

Plant Physiol Biochem. 2015 Nov;96:270-80. doi: 10.1016/j.plaphy.2015.08.012. Epub 2015 Aug 19.

PMID:
26318144
35.

Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status.

Bodei L, Kidd M, Modlin IM, Prasad V, Severi S, Ambrosini V, Kwekkeboom DJ, Krenning EP, Baum RP, Paganelli G, Drozdov I.

Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1341-52. doi: 10.1007/s00259-015-3075-9. Epub 2015 May 7.

PMID:
25947577
36.

Early outcome of high energy Laser (Excimer) facilitated coronary angioplasty ON hARD and complex calcified and balloOn-resistant coronary lesions: LEONARDO Study.

Ambrosini V, Sorropago G, Laurenzano E, Golino L, Casafina A, Schiano V, Gabrielli G, Ettori F, Chizzola G, Bernardi G, Spedicato L, Armigliato P, Spampanato C, Furegato M.

Cardiovasc Revasc Med. 2015 Apr-May;16(3):141-6. doi: 10.1016/j.carrev.2015.02.002. Epub 2015 Feb 11.

PMID:
25708003
37.

Current status of PET imaging of neuroendocrine tumours ([18F]FDOPA, [68Ga]tracers, [11C]/[18F]-HTP).

Ambrosini V, Morigi JJ, Nanni C, Castellucci P, Fanti S.

Q J Nucl Med Mol Imaging. 2015 Mar;59(1):58-69. Epub 2015 Feb 12. Review.

PMID:
25677589
38.

Lung cancer associated with cystic airspaces.

Mascalchi M, Attinà D, Bertelli E, Falchini M, Vella A, Pegna AL, Ambrosini V, Zompatori M.

J Comput Assist Tomogr. 2015 Jan-Feb;39(1):102-8. doi: 10.1097/RCT.0000000000000154.

PMID:
25279848
39.

The use of gallium-68 labeled somatostatin receptors in PET/CT imaging.

Ambrosini V, Nanni C, Fanti S.

PET Clin. 2014 Jul;9(3):323-9. doi: 10.1016/j.cpet.2014.03.008. Epub 2014 Apr 26. Review.

PMID:
25030395
40.

68Ga-DOTA-peptides in the diagnosis of NET.

Ambrosini V, Fanti S.

PET Clin. 2014 Jan;9(1):37-42. doi: 10.1016/j.cpet.2013.08.007. Epub 2013 Sep 14. Review.

PMID:
25029932
41.

Incidentally detected increased FDG uptake in bowel and its correlation with hystopathological data: our experience in a case series study.

Grassi I, Castellucci P, Nanni C, Ghedini P, Ambrosini V, Allegri V, Montini GC, Guidalotti PL, Fanti S.

Curr Radiopharm. 2014;7(2):107-14. Review.

PMID:
24934797
42.

Diagnostic accuracy of FDG PET/CT in mediastinal lymph nodes from lung cancer.

Ambrosini V, Fanti S, Chengazi VU, Rubello D.

Eur J Radiol. 2014 Aug;83(8):1301-2. doi: 10.1016/j.ejrad.2014.04.035. Epub 2014 May 17. No abstract available.

PMID:
24917223
43.

68Ga DOTANOC PET/CT detects primary malignant insulinoma.

Ambrosini V, Campana D, Nanni C, Marzola MC, Rubello D, Fanti S.

Clin Nucl Med. 2015 Feb;40(2):e132-3. doi: 10.1097/RLU.0000000000000447.

PMID:
24830876
44.

SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation.

Stabile E, Pucciarelli A, Cota L, Sorropago G, Tesorio T, Salemme L, Popusoi G, Ambrosini V, Cioppa A, Agrusta M, Catapano D, Moscariello C, Trimarco B, Esposito G, Rubino P.

Int J Cardiol. 2014 Jul 1;174(3):624-7. doi: 10.1016/j.ijcard.2014.04.170. Epub 2014 Apr 21.

PMID:
24809922
45.

FDG PET/CT in autoimmune pancreatitis.

Nanni C, Romagnoli R, Rambaldi I, Caroli P, Matteucci F, Ambrosini V, Re G, Fanti S.

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1264-5. doi: 10.1007/s00259-014-2699-5. Epub 2014 Feb 22. No abstract available.

PMID:
24562645
46.

Molecular imaging of pulmonary nodules.

Maffione AM, Grassetto G, Rampin L, Chondrogiannis S, Marzola MC, Ambrosini V, Rubello D.

AJR Am J Roentgenol. 2014 Mar;202(3):W217-23. doi: 10.2214/AJR.13.11733.

PMID:
24555617
47.

Response to Dr Ho.

Kanter MH, Nguyen M, Klau MH, Spiegel NH, Ambrosini VL.

Perm J. 2013 Fall;17(4):94. No abstract available.

PMID:
24511590
48.

Performance of FDG PET/ceCT in the evaluation of patients with lung cancer.

Nanni C, Rossetti V, Zompatori M, Ambrosini V, Montesi V, Mascherini D, Pettinato C, Marzola MC, Colletti PM, Rubello D, Fanti S.

Biomed Pharmacother. 2014 Mar;68(2):219-23. doi: 10.1016/j.biopha.2013.11.002. Epub 2014 Jan 10.

PMID:
24486108
49.

What does professionalism mean to the physician?

Kanter MH, Nguyen M, Klau MH, Spiegel NH, Ambrosini VL.

Perm J. 2013 Summer;17(3):87-90. doi: 10.7812/TPP/12-120.

50.

Excimer Laser LEsion modification to expand non-dilatable stents: the ELLEMENT registry.

Latib A, Takagi K, Chizzola G, Tobis J, Ambrosini V, Niccoli G, Sardella G, DiSalvo ME, Armigliato P, Valgimigli M, Tarsia G, Gabrielli G, Lazar L, Maffeo D, Colombo A.

Cardiovasc Revasc Med. 2014 Jan;15(1):8-12. doi: 10.1016/j.carrev.2013.10.005. Epub 2013 Oct 22.

PMID:
24290659

Supplemental Content

Loading ...
Support Center